MedTrace Logo

Optional Sub-study to Intraoperative Imaging With ICG Registry

NCT02651246 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 291

Last updated 2021-06-24

No results posted yet for this study

Summary

The primary goal of this optional sub-study is to record what tissues fluoresce in the operating room, and then to identify if these lesions are cancer when the histopathology is performed.

Conditions

  • Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) Cancer
  • Cancer of the Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut), Sarcoma Cancer
  • Cancer of Neuro-onc, Parathyroid, Desmoid Tumors, Melanoma Cancer

Interventions

OTHER

data collection

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Sunil Singhal, MD, Ph.D · Abramson Cancer Center at Penn Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02651246 on ClinicalTrials.gov